⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
LabCentral Names Kamran Tavangar Head of Science Strategy
prnewswire.com
NVS
Biomedical and ICT Convergence Market Research Report 2025-2030: Opportunities in Developing Connected Medical Devices, Enhancing Precision Medicine, and Improving Healthcare Delivery
globenewswire.com
ABT
AMGN
ADI
AZN
BIIB
BIO
XRAY
GEHC
GILD
HON
JNJ
MDLZ
MRK
NVS
NVO
NXPI
PFE
SNY
SWX
STM
TEI
TXN
TMO
ZBH
FMS
JBL
LMT
MDT
ON
PHI
SYK
WMT
SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer's Disease
prnewswire.com
NVS
Alamar Biosciences gibt Abschluss der überzeichneten Wandelanleihe-Finanzierung und Erweiterung des Führungsteams bekannt USA - Deutsch USA - Français USA - English APAC - English USA - English USA - čeština
prnewswire.com
AMGN
ILMN
VRTX
RIVN
TROW
PRGS
ALNY
REGN
GILD
BMY
MRK
ABBV
AZN
SNY
NVS
XRAY
EVTC
MYGN
RVTY
VTRS
BIIB
MDLZ
PFE
SNDX
EXAS
CRSP
NTRA
ON
IDXX
MDT
SYK
ISRG
DXCM
COO
AMZN
GOOG
MSFT
NVDA
IBM
INTC
QCOM
AMD
MU
ADBE
CRM
ORCL
SAP
CSCO
ACN
HPQ
DELL
MSCI
FIS
PAYX
ADP
BBBY
ROST
TJX
MCHP
NXPI
SNPS
CDNS
WDC
STX
KLAC
LRCX
AMAT
CTAS
PAYC
NOW
DDOG
ZS
PANW
FTNT
SNOW
PYPL
V
MA
AXP
BAC
JPM
WFC
C
GS
MS
SCHW
ELAN
ZTS
ALGN
XOM
CVX
KO
PEP
MCD
DIS
CMCSA
VZ
T
NFLX
Over The Counter (OTC) Drugs Market is expected to generate a revenue of USD 367.08 Billion by 2032, Globally, at 8.10% CAGR: Verified Market Research®
globenewswire.com
JNJ
BHC
GSK
NVS
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
globenewswire.com
NVS
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
globenewswire.com
NVS
January 2026 Sustainability Portfolio Launches With Exclusive Insights From Novartis, BW LPG, Savills, Amazon and More
prnewswire.com
NVS
BWLP
AMZN
BizClik Launches January 2026 Sustainability Portfolio With Insights From Novartis and Amazon
globenewswire.com
NVS
AMZN
Psoriasis Market to Exhibit Growth at a CAGR of 1.7% During the Forecast Period (2025-2034), Owing to Continuous Innovation in Biologic Therapies and Approval of Oral Small Molecules | DelveInsight
prnewswire.com
TAK
JNJ
CANF
AMGN
ABBV
NVS
BMY
AZN
BHC
LLY
UCB
LEO
REGN
XBI
IBB
JAZZ
MRK
SNY
GILD
INCY
PFE
LULU
PRTH
DRH
BIIB
TEVA
ARCT
HRMY
CRSP
NTLA
EDIT
SNOW
DDOG
CRM
GOOG
MSFT
AAPL
AMZN
TSLA
NVDA
META
NFLX
DIS
CMCSA
VZ
T
KO
PEP
MCD
SBUX
HD
EXAS
ILMN
BNTX
MRNA
XOM
CVX
BA
CAT
GE
IBM
INTC
CSCO
ADBE
QCOM
AMAT
MU
ORCL
ACN
COST
WMT
TGT
LOW
HON
GD
LMT
RTX
BAX